XML 56 R44.htm IDEA: XBRL DOCUMENT v3.21.2
REVERSE RECAPITALIZATION- Narrative (Details)
$ / shares in Units, $ in Thousands
9 Months Ended
Jul. 23, 2021
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Sep. 30, 2020
USD ($)
shares
Jul. 22, 2021
USD ($)
shares
Jun. 30, 2021
shares
[1]
Dec. 31, 2020
USD ($)
shares
Jun. 30, 2020
shares
[1]
Dec. 31, 2019
USD ($)
shares
Schedule Of Reverse Recapitalization [Line Items]                
Common stock, shares outstanding (in shares) 1,618,621,534 1,641,642,816   451,295,965   28,791,702    
Share conversion deemed value (in dollars per share) | $ / shares $ 10.00              
Recapitalization exchange ratio 2.644              
Stock converted, reverse recapitalization (in shares) 1,193,226,511              
Equity awards outstanding (in shares)       42,182,931        
Equity awards converted (in shares) 111,531,080              
Convertible preferred stock, shares outstanding (in shares)   0 [1] 825,191,683 [1] 437,182,072 1,155,909,367 957,159,704 [1] 667,574,747 502,582,534 [1]
Options outstanding (in shares)   67,013,622   25,764,610   70,675,318    
Options converted (in shares) 68,121,210              
Non-option equity awards outstanding (in shares)       16,418,321        
Non-option equity awards converted (in shares) 43,409,870              
Proceeds from PIPE investment | $ $ 2,500,000              
Working capital loan converted, amount | $ $ 1,500              
Warrants issued for conversion of debt (in shares) 1,500,000              
Price per warrant for warrants issued for conversion of debt (in dollars per share) | $ / shares $ 1.00              
Sponsor earnback shares (in shares) 17,250,000              
Sponsor earnback warrants (in shares) 14,783,333              
Proceeds from the reverse recapitalization | $ $ 4,439,200 $ 4,439,153 $ 0          
Cash received upon completion of merger | $ 2,070,100              
Cash | $   $ 4,796,880 $ 512,675 $ 400   $ 614,412   $ 351,684
Payments for repurchase of common stock | $ $ 200              
Shares repurchased (in shares) 21,644              
Reverse recapitalization, transaction costs incurred | $ $ 38,900              
Reverse recapitalizations, reduction to additional paid-in capital | $ 36,200              
Transaction costs expensed | $ 2,700              
Proceeds from reverse recapitalization, net of transaction costs | $ $ 4,400,300              
Churchill                
Schedule Of Reverse Recapitalization [Line Items]                
Common stock, shares outstanding (in shares)       207,000,000        
Stock repurchased during period, shares (in shares) 21,644              
Stock repurchased during period, value | $ $ 200              
Reverse recapitalization transaction costs paid to date | $       $ 131,400        
Legacy Common Shareholders                
Schedule Of Reverse Recapitalization [Line Items]                
Stock converted, reverse recapitalization (in shares) 1,193,226,511              
Legacy Preferred Shareholders                
Schedule Of Reverse Recapitalization [Line Items]                
Stock converted, reverse recapitalization (in shares) 437,182,072              
PIPE Investors                
Schedule Of Reverse Recapitalization [Line Items]                
Shares outstanding prior to merger (in shares) 166,666,667              
Preferred stock, price (in dollars per share) | $ / shares $ 15.00              
[1] The number of shares of convertible preferred stock and common stock issued and outstanding prior to the Merger have been retroactively adjusted by the Exchange Ratio to give effect to the reverse recapitalization treatment of the Merger. See Note 1 - Description of Business and Note 3 - Reverse Capitalization for more information.